Retrospective Study to Describe Prevalence of Hyperkalemia in Russian Population Based on Large Laboratory Network (HEKATE)

AstraZeneca53,940 enrolled

Overview

This is a cross-sectional retrospective study of laboratory records of patients who take electrolytes blood tests containing the data of the serum potassium level. This study is an observational one, and there is no intervention into routine clinical practice either in terms of therapy, or special examinations.

Study Type

OBSERVATIONAL

Enrollment

53,940

Conditions

Hyperkalemia Elevated Plasma K+ Cardiovascular Disease (CVD)

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Males and females tested in the Russian centres of INVITRO laboratory from 01.01.2015 till 31.12.2016; * 18 years and older; * Available electrolytes blood test containing of the serum potassium level of the unique patient fits for interpretation. Exclusion Criteria: * Blood test cannot be interpreted due to various reasons. * Blood samples with sing of hemolysis

Locations (1)

Invitro

Moscow, Russia

Outcomes

Primary Outcomes

the proportion of the individuals with the serum potassium level higher than 5.0, 5.5, and 6.0 mmol/L

To determine the proportion of the individuals with the serum potassium level higher than 5.0, 5.5, and 6.0 mmol/L based on INVITRO laboratory database during 2015-2016 years.

Time frame: One day

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.